本文へスキップ
Likelier

行動 vs. 不行動の後悔

今、卵子または精子を凍結する vs. 適切な状況を待つ

行動した場合

今、卵子・精子を凍結する

16%

行動しなかった場合

待って、機が熟したら自然に妊娠を試みる

51%

それぞれの選択を後で後悔した人の割合。バーと完全な記録は下に表示されます。


家族

最終確認 2026-05-04

証拠の質 4.0/5

8次元のレビュー評価。基準は 品質ルーブリック 。各次元は1〜5で評価。

D1 出典の検証
4/5
D2 出典の権威性と独立性
4/5
D3 後悔率の正確性
3/5
D4 出典の比較可能性
3/5
D5 ギロヴィッチ・パターン
5/5
D6 文章の質
5/5
D7 注意事項の完全性
4/5
D8 サンプルの質
4/5
平均 4.0/5
A flat vector illustration of a laboratory cryo-storage canister and a calendar with an open date

行動への後悔

今、卵子・精子を凍結する

16%

卵子凍結を受けた患者の約16%が、その決定について中等度から重度の後悔を表明している

選択的卵母細胞凍結保存を受けた25-40歳の女性(Hammarberg et al. 2017; Stoop et al.系統的レビュー)

凍結後1-3年

不作為への後悔

待って、機が熟したら自然に妊娠を試みる

51%

計画的卵子凍結を検討したが実行しないと決めた女性の約51%が、その決定について中等度から重度の後悔を報告している

遅らせた出産試行後に不妊を経験した35-45歳の女性(ESHRE/ASRMカウンセリングデータ;Wennberg et al. 2016)

不妊診断またはART失敗後に調査

この選択を後悔した割合

inaction dominates — 不作為が優勢 — 多くは行動しなかったことを後悔しています。

関連する決断

意味的に類似する決断 — 同じ領域、異なるトレードオフ。

family

早期 vs. 晩期の親になること

この選択を後悔した割合

不作為が優勢

不作為の後悔が1.7倍高い

健康

不妊治療を追求 vs. 子なしを受け入れる

この選択を後悔した割合

不作為が優勢

不作為の後悔が1.7倍高い

family

代理出産 vs. 子なし生活

この選択を後悔した割合

不作為が優勢

不作為の後悔が2.1倍高い

family

IVF vs. 養子縁組

この選択を後悔した割合

行動が優勢

行動の後悔が3.8倍高い

健康

DNA祖先・健康テスト vs. 受けない

この選択を後悔した割合

不作為が優勢

不作為の後悔が4.7倍高い

健康

卵管結紮術

この選択を後悔した割合

行動が優勢

行動の後悔が1.4倍高い

健康

事前指示書の作成タイミング

この選択を後悔した割合

不作為が優勢

不作為の後悔が10.0倍高い

family

中国:結婚を遅らせる vs. 予定通り結婚

この選択を後悔した割合

行動が優勢

行動の後悔が2.2倍高い

Oocyte cryopreservation — egg freezing — produces clinically meaningful live birth rates when oocytes are retrieved before age 35, with steep age-related decline thereafter. Cobo et al.’s 2016 Fertility and Sterility cohort of 1,468 women found a live birth rate per patient of 50% for women aged 35 or younger versus 22.9% for women aged 36 or older, with cumulative live birth rates climbing sharply once 8–10 mature oocytes were banked — and rising far more steeply for younger women than older ones. The ASRM Practice Committee concluded in its 2013 guideline that oocyte vitrification and warming should no longer be considered experimental, with fertilization and pregnancy rates similar to fresh IVF/ICSI for young women. Greenwood and colleagues’ 2018 retrospective survey of 201 women who had frozen eggs found that only 16% (33 women) experienced moderate-to-severe decision regret, while 89% affirmed they would be happy they froze even if they never use the eggs; regret was concentrated among women who banked fewer eggs and who felt under-informed before the procedure.

The asymmetry in the regret data is stark. A prospective cohort by Jaswa, Greenwood and colleagues (2023) followed 173 women who consulted about planned egg freezing and surveyed them six months later: moderate-to-severe regret was just 9% among women who went ahead and froze, but 51% among women who decided not to pursue treatment. This is a textbook inaction-regret pattern: the action (freezing) has a modest regret rate driven by uncertainty about whether the eggs will ever be needed; the inaction (declining) carries a much higher regret rate concentrated in those who later question having passed up the option.

Sperm freezing presents a simpler version of the same decision. Male gamete cryopreservation is substantially cheaper (typically under $1,000 vs. $10,000–$20,000 for oocyte cycles), requires no invasive procedure or hormone stimulation, and does not face the same age-related quality decline until the late 40s or 50s. For men in circumstances where biological parenthood is a desired but uncertain future goal, sperm banking resolves the optionality question at low cost and burden. The asymmetry in action vs. inaction regret is likely wider for sperm than for oocytes precisely because the cost of acting is so much lower relative to the regret of not having acted.

出典: 行動

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

1/2 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] Fertility and Sterility — To freeze or not to freeze: decision regret and satisfaction following elective oocyte cryopreservation
    To freeze or not to freeze: decision regret and satisfaction following elective oocyte cryopreservation
    統計値
    16% of women (33 of 201) who underwent elective oocyte cryopreservation experienced moderate-to-severe decision regret; 89% affirmed they will be happy they froze eggs even if they never use them
    抜粋
    “"Thirty-three women (16%) experienced moderate to severe decision regret. One hundred eighty-three (89%) affirmed they will be happy they froze eggs, even if they never use them. ... A greater number of eggs frozen, perceived adequacy of information prior to EOC, and patient-estimated likelihood of future use were associated with reduced decision regret." ”
    出典データ
    2018-06-01
    アクセス日
    2026-06-30
    計算過程
    Greenwood/Jaswa et al. 2018, Fertility and Sterility 109(6):1097-1104 (PMID 29807657). Retrospective cohort survey of 201 women who underwent elective oocyte cryopreservation 2012–2016. 33 of 201 (16%) scored moderate-to-severe on the Decision Regret Scale (DRS>25); 89% affirmed they would be happy they froze even if they never use the eggs. The 16% is used directly as the action-side regret_rate.
  2. [2] Fertility and Sterility — Oocyte vitrification as an efficient option for elective fertility preservation 検証済み
    Oocyte vitrification as an efficient option for elective fertility preservation
    統計値
    Live birth rate per patient from vitrified oocytes was 50% for women ≤35 vs. 22.9% for women ≥36; cumulative live birth rate rose sharply with at least 8–10 mature oocytes banked, much steeper for younger women
    抜粋
    “"Live birth rate per patient was higher in women ≤35 years old than ≥36 years old (50% [95% CI 32.7-67.3] vs. 22.9% [95% CI 14.9-30.9]). ... At least 8-10 metaphase II oocytes are necessary to achieve reasonable success. ... The gain in CLBR was sharp from 5 (15.4%) to 8 oocytes (40.8%) [in the ≤35-year-old group]... A milder increase (4.9% gain) was observed in the ≥36-year-old group." ”
    出典データ
    2016-03-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Cobo et al. 2016, Fertility and Sterility 105(3):755-764 (PMID 26688429) — retrospective multicenter cohort of 1,468 women who underwent elective fertility preservation 2007–2015 (137 returned to use oocytes; 40 babies born). Live birth rate per patient was 50% for women ≤35 vs. 22.9% for ≥36; cumulative live birth climbs steeply with 8–10+ mature oocytes and is far more favorable for younger women. Contextualises why freezing earlier produces better outcomes and why delayed freezing increases the probability of reproductive regret.

出典: 不作為

根拠台帳

以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。

2/2 件の出典が引用元と一字一句一致することを独立して検証済み

  1. [1] Journal of Assisted Reproduction and Genetics — Decision regret among women considering planned oocyte cryopreservation: a prospective cohort study 検証済み
    Decision regret among women considering planned oocyte cryopreservation: a prospective cohort study
    統計値
    Moderate-to-severe regret was 9% over the decision to freeze eggs vs. 51% over the decision not to pursue treatment, among 173 women followed prospectively
    抜粋
    “"A total of 173 women seen in consultation for planned OC were followed prospectively. Surveys were administered at (1) baseline (< 1 week after initial consultation) and (2) follow-up, 6 months after planned OC. ... The incidence of moderate-to-severe regret over the decision to freeze eggs was 9% compared to 51% over the decision not to pursue treatment." ”
    出典データ
    2023-06-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    Jaswa/Greenwood et al. 2023, J Assist Reprod Genet 40(6):1281-1290 (PMID 37058259) — prospective cohort of 173 women consulting for planned oocyte cryopreservation, surveyed at baseline and 6 months. Moderate-to-severe decision regret was 9% among women who froze vs. 51% among women who decided NOT to pursue treatment. The 51% not-pursue-treatment figure anchors the inaction-side regret rate; the comparison population is women who considered and declined freezing, not the broader infertile population, so the display is labeled accordingly.
  2. [2] American Society for Reproductive Medicine (ASRM) Practice Committee — Mature oocyte cryopreservation: a guideline 検証済み
    Mature oocyte cryopreservation: a guideline
    統計値
    ASRM concluded that oocyte vitrification and warming should no longer be considered experimental; fertilization and pregnancy rates are similar to fresh IVF/ICSI for young women
    抜粋
    “"There is good evidence that fertilization and pregnancy rates are similar to IVF/ICSI with fresh oocytes when vitrified/warmed oocytes are used as part of IVF/ICSI for young women. ... Evidence indicates that oocyte vitrification and warming should no longer be considered experimental." ”
    出典データ
    2013-01-01
    アクセス日
    2026-06-30
    検証
    グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
    計算過程
    ASRM/SART Practice Committee guideline, Fertil Steril 2013;99(1):37-43 (PMID 23083924). Establishes that oocyte vitrification is no longer experimental and that young-women outcomes match fresh IVF/ICSI. The guideline does not itself address elective freezing-to-delay or measure patient regret; it is cited only for the established clinical-validity claim, not for any regret figure.

注意事項

The cleanest comparison comes from the same prospective cohort (Jaswa/Greenwood 2023): among women who consulted about planned egg freezing, 9% who froze later reported moderate-to-severe regret versus 51% who declined treatment. The headline action-side rate (16%) is drawn instead from a separate retrospective survey (Greenwood 2018) of women who had already frozen, which uses the same Decision Regret Scale but a different cohort and timing; the two action-side figures (9% prospective, 16% retrospective) bracket the true rate. Both inaction- and action-side populations are women who actively considered freezing, so neither captures women who never engaged with the option at all. The 16% action-side rate may still understate future regret among women who freeze but never use the oocytes (because they conceived naturally or decided not to have children) — some may later feel the cost and burden were unnecessary. The Cobo 2016 data show steep age-related decline in success rates; the "right" decision depends heavily on age at consideration, and the analysis most strongly supports acting before 35. Sperm freezing (the male equivalent) is substantially cheaper, less burdensome, and has no age-related quality decline until the 50s, making the calculus for sperm freezing substantially clearer than for oocytes.

生データ: /api/decisions.json

このデバイスで最近見た項目